These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 28700897)

  • 1. A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis.
    Alaarg A; Senders ML; Varela-Moreira A; Pérez-Medina C; Zhao Y; Tang J; Fay F; Reiner T; Fayad ZA; Hennink WE; Metselaar JM; Mulder WJM; Storm G
    J Control Release; 2017 Sep; 262():47-57. PubMed ID: 28700897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.
    Duivenvoorden R; Tang J; Cormode DP; Mieszawska AJ; Izquierdo-Garcia D; Ozcan C; Otten MJ; Zaidi N; Lobatto ME; van Rijs SM; Priem B; Kuan EL; Martel C; Hewing B; Sager H; Nahrendorf M; Randolph GJ; Stroes ES; Fuster V; Fisher EA; Fayad ZA; Mulder WJ
    Nat Commun; 2014; 5():3065. PubMed ID: 24445279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.
    Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y
    EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emodin promotes atherosclerotic plaque stability in fat-fed apolipoprotein E-deficient mice.
    Zhou M; Xu H; Pan L; Wen J; Guo Y; Chen K
    Tohoku J Exp Med; 2008 May; 215(1):61-9. PubMed ID: 18509236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
    Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
    J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model.
    Aprahamian T; Bonegio R; Rizzo J; Perlman H; Lefer DJ; Rifkin IR; Walsh K
    J Immunol; 2006 Sep; 177(5):3028-34. PubMed ID: 16920939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid-coated polymeric micelles with hydrogen peroxide scavenging to encapsulate statins for alleviating atherosclerosis.
    Mu D; Li J; Qi Y; Sun X; Liu Y; Shen S; Li Y; Xu B; Zhang B
    J Nanobiotechnology; 2020 Dec; 18(1):179. PubMed ID: 33287831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
    Stoll G; Bendszus M
    Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages.
    Ayala-López W; Xia W; Varghese B; Low PS
    J Nucl Med; 2010 May; 51(5):768-74. PubMed ID: 20395331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(-/-) mice.
    Wang Q; Wang Y; Liu S; Sha X; Song X; Dai Y; Zhao M; Cai L; Xu K; Li J
    J Nanobiotechnology; 2021 Jul; 19(1):222. PubMed ID: 34320994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
    Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice.
    Jung C; Kaul MG; Bruns OT; Dučić T; Freund B; Heine M; Reimer R; Meents A; Salmen SC; Weller H; Nielsen P; Adam G; Heeren J; Ittrich H
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):303-11. PubMed ID: 24357264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeted delivery of statins and nucleic acids by chitosan-based nanoparticles for enhanced antiatherosclerotic efficacy.
    Jiang T; Xu L; Zhao M; Kong F; Lu X; Tang C; Yin C
    Biomaterials; 2022 Jan; 280():121324. PubMed ID: 34933253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.